Neorelium (Diazepam)

Diazepam binds to the benzodiazepine site on the GABA‑A receptor, enhancing the inhibitory effect of the neurotransmitter GABA. This increases chloride ion influx, hyperpolarising neurons and reducing excitability, which produces anxiolytic, anticonvulsant, muscle‑relaxant and sedative effects.

The appropriate dose of Neorelium is determined by the prescribing clinician based on the specific indication, patient age, weight, liver function and concomitant therapies. Dosage regimens are individualized and should follow the prescriber’s written instructions.

Safety data for diazepam in pregnancy and lactation are limited. It is classified as a potential risk to the fetus and may pass into breast milk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential benefits and risks with their healthcare provider before using Neorelium.

To place an order, submit an enquiry on the Neorelium product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Neorelium (diazepam) has a relatively long half‑life compared with agents such as lorazepam or alprazolam, providing prolonged therapeutic coverage but also a higher potential for accumulation. Its potency, onset of action and side‑effect profile are comparable to other benzodiazepines, making choice dependent on clinical context, duration of therapy and patient tolerance.

Neorelium should be stored at ambient temperature, below 25 °C, in its original packaging to protect from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged or the tablet appears discoloured.

Neorelium is intended for oral administration. Swallow the tablet whole with a glass of water; do not crush, chew or split unless specifically instructed by a healthcare professional. The exact dosing schedule is set by the prescriber.

Serious risks include respiratory depression, severe hypotension, paradoxical reactions such as agitation or aggression, dependence with withdrawal syndrome on abrupt discontinuation, and rare severe skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience difficulty breathing, extreme drowsiness, rash or any unexpected behavioural changes.

Neorelium is contraindicated in individuals with known hypersensitivity to diazepam or other benzodiazepines, those with acute narrow‑angle glaucoma, and patients with severe respiratory insufficiency. Caution is also advised for patients with a history of substance